Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Travel Awards - Institute Community Support

McGill University

$1,500.00

Comparability of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scores between cancer and systemic sclerosis: An assessment of differential item functioning

FY 2016-17

Summary
The aim of this study was to establish whether the FACIT-F, which is a scale used to measure fatigue in chronic populations, has comparable scoring metrics in cancer and scleroderma patients. In other words, we assessed whether cancer and scleroderma patients with similar levels of fatigue would have similar scores on the FACIT-F. We found that the FACIT-F behaved similarly when administered to patients with cancer and patients with scleroderma.
Program
Travel Awards - Institute Community Support
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
352241
Name
Coroiu Adina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Institute of Health Services and Policy Research
Projecttitle
Comparability of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) scores between cancer and systemic sclerosis: An assessment of differential item functioning
Programtype2
Undefined
Orgnameinp2
McGill University
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Cancer Patients; Differential Item Functioning (Dif); Facit-Fatigue; Ics Travel Awards; Measurement Equivalence; Systemic Sclerosis Patients
Abstract
The aim of this study was to establish whether the FACIT-F, which is a scale used to measure fatigue in chronic populations, has comparable scoring metrics in cancer and scleroderma patients. In other words, we assessed whether cancer and scleroderma patients with similar levels of fatigue would have similar scores on the FACIT-F. We found that the FACIT-F behaved similarly when administered to patients with cancer and patients with scleroderma.
Competitiondate
201607
Approvedterm2
1 yr 0 mth
Pinamesdelim
Coroiu, Adina
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Hlth Serv & Policy Res~ $1,500~ $0~